E-ISSN 2231-3206 | ISSN 2320-4672
 
2024, Vol: 14, Issue: 10
14 / 10Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles
Required files to be uploaded

Authorship Declaration

Original Research 


Effectiveness and safety of amitriptyline, duloxetine, and pregabalin in painful diabetic neuropathy: An observational study

Suji V Sumedhan, Vinu Wilson, Manoj P, Rajamony P N.


Abstract
Background: Studies comparing the real-world effectiveness, safety, and effect on quality of life (QoL) of drugs for painful diabetic peripheral neuropathy (DPN) are scarce.

Aims and Objectives: The aim of the study was to compare effectiveness, safety and effect on QoL of amitriptyline (AMY), duloxetine (DUL) and pregabalin (PGN) in DPN.

Materials and Methods: After ethics committee approval and informed consent, 75 outpatients (25 each) prescribed any one of above drugs were consecutively recruited in a prospective and observational study. Drug effectiveness was assessed by comparing difference in mean monthly visual analogue scale (VAS) score from baseline, obtained from pain diary. QoL was assessed by comparing total and domain-wise score on Nottingham health profile (NHP) questionnaire. Safety was assessed by comparing frequency of adverse drug reactions (ADRs). Qualitative and quantitative outcome measures were compared using Chi-square test and one-way analysis of variance, respectively. P < 0.05 was considered statistically significant.

Results: The difference in mean monthly VAS scores at the end of 4, 8, and 12 weeks was similar between the three drugs. Patients on PGN had smaller beneficial effects in total as well as emotional, energy, and sleep domains of NHP compared to other drugs. Sedation and dizziness occurred with all drugs but PGN had least incidence of sedation.

Conclusion: AMY, DUL and PGN are equally effective and safe in DPN. Although PGN did not improve QoL unlike AMY and DUL, it had lower incidence of sedation.

Key words: Amitriptyline; Duloxetine; Pregabalin; Diabetic Neuropathy; Quality of Life; Safety


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Suji V Sumedhan
Articles by Vinu Wilson
Articles by Manoj P
Articles by Rajamony P N
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Sumedhan SV, Wilson V, P M, N RP. Effectiveness and safety of amitriptyline, duloxetine, and pregabalin in painful diabetic neuropathy: An observational study. Natl J Physiol Pharm Pharmacol. 2023; 13(7): 1374-1379. doi:10.5455/njppp.2023.13.08416202208122022

Web Style

Sumedhan SV, Wilson V, P M, N RP. Effectiveness and safety of amitriptyline, duloxetine, and pregabalin in painful diabetic neuropathy: An observational study. https://www.njppp.com/?mno=109647 [Access: October 04, 2024]. doi:10.5455/njppp.2023.13.08416202208122022

AMA (American Medical Association) Style

Sumedhan SV, Wilson V, P M, N RP. Effectiveness and safety of amitriptyline, duloxetine, and pregabalin in painful diabetic neuropathy: An observational study. Natl J Physiol Pharm Pharmacol. 2023; 13(7): 1374-1379. doi:10.5455/njppp.2023.13.08416202208122022


Vancouver/ICMJE Style

Sumedhan SV, Wilson V, P M, N RP. Effectiveness and safety of amitriptyline, duloxetine, and pregabalin in painful diabetic neuropathy: An observational study. Natl J Physiol Pharm Pharmacol. (2023), [cited October 04, 2024]; 13(7): 1374-1379. doi:10.5455/njppp.2023.13.08416202208122022


Harvard Style

Sumedhan, S. V., Wilson, . V., P, . M. & N, . R. P. (2023) Effectiveness and safety of amitriptyline, duloxetine, and pregabalin in painful diabetic neuropathy: An observational study. Natl J Physiol Pharm Pharmacol, 13 (7), 1374-1379. doi:10.5455/njppp.2023.13.08416202208122022


Turabian Style

Sumedhan, Suji V, Vinu Wilson, Manoj P, and Rajamony P N. 2023. Effectiveness and safety of amitriptyline, duloxetine, and pregabalin in painful diabetic neuropathy: An observational study. National Journal of Physiology, Pharmacy and Pharmacology, 13 (7), 1374-1379. doi:10.5455/njppp.2023.13.08416202208122022


Chicago Style

Sumedhan, Suji V, Vinu Wilson, Manoj P, and Rajamony P N. "Effectiveness and safety of amitriptyline, duloxetine, and pregabalin in painful diabetic neuropathy: An observational study." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 1374-1379. doi:10.5455/njppp.2023.13.08416202208122022


MLA (The Modern Language Association) Style

Sumedhan, Suji V, Vinu Wilson, Manoj P, and Rajamony P N. "Effectiveness and safety of amitriptyline, duloxetine, and pregabalin in painful diabetic neuropathy: An observational study." National Journal of Physiology, Pharmacy and Pharmacology 13.7 (2023), 1374-1379. Print. doi:10.5455/njppp.2023.13.08416202208122022


APA (American Psychological Association) Style

Sumedhan, S. V., Wilson, . V., P, . M. & N, . R. P. (2023) Effectiveness and safety of amitriptyline, duloxetine, and pregabalin in painful diabetic neuropathy: An observational study. National Journal of Physiology, Pharmacy and Pharmacology, 13 (7), 1374-1379. doi:10.5455/njppp.2023.13.08416202208122022




Most Viewed Articles
Most Accessed Articles

  • Applications of computer science in Pharmacy: An overview
    Shivraj Popat Jadhav, Komal Nikam, Anand Gandhi, Kishor Salunkhe, Narendra Shinde.
    Natl J Physiol Pharm Pharmacol. 2012; 2(1): 1-9
    » Abstract

  • How to calculate sample size in animal studies?
    Hitesh Shah
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 35-39
    » Abstract

  • Chlorhexidine:The gold standard in chemical plaque control [English]
    Setu mathur, Tanu mathur,Rahul shrivastava, Rohit khatri
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 45-50
    » Abstract

  • Assessment of Nutritional Status of Pregnant Women Attending the City Tebessa PMI (Algeria) [English]
    Taleb Salima, Kaibi Mounira, Deghboudj Nadjia
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 97-105
    » Abstract

  • Difference in pulmonary function test among the athletic and sedentary population
    ShobhaRani Vedala, Niranjan Paul, Abhay B Mane
    Natl J Physiol Pharm Pharmacol. 2013; 3(2): 118-123
    » Abstract » doi: 10.5455/njppp.2013.3.109-114

    •
    Most Downloaded
    Top Downloaded Articles

  • How to calculate sample size in animal studies?
    Hitesh Shah
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 35-39
    » Abstract

  • Applications of computer science in Pharmacy: An overview
    Shivraj Popat Jadhav, Komal Nikam, Anand Gandhi, Kishor Salunkhe, Narendra Shinde.
    Natl J Physiol Pharm Pharmacol. 2012; 2(1): 1-9
    » Abstract

  • Evaluation of potential drug-drug interaction in indoor patients of pediatric department of tertiary care hospital
    Simran Patel, Mayur Chaudhari, Nrupal Patel
    Natl J Physiol Pharm Pharmacol. 2019; 9(10): 1012-1016
    » Abstract » doi: 10.5455/njppp.2019.9.0725209072019

  • Chlorhexidine:The gold standard in chemical plaque control [English]
    Setu mathur, Tanu mathur,Rahul shrivastava, Rohit khatri
    Natl J Physiol Pharm Pharmacol. 2011; 1(2): 45-50
    » Abstract

  • Analyzing Pharmaceutical Industry [English]
    Veselin Tima Dickov, Dragan Mitrovic, Boris Milan Kuzman
    Natl J Physiol Pharm Pharmacol. 2011; 1(1): 1-8
    » Abstract » doi: 10.5455/njppp.2011.1.1-8

    •
    Most Cited Articles
    Most Cited Articles

    About National Journal of Physiology, Pharmacy and Pharmacology

      National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal.  The journal is having open access polic ... Read more.



    For best results, please use Internet Explorer or Google Chrome.

    Contact Information

    Eldaghayes Publisher

    www.eldagpublisher.com 

     
    All correspondence should be addressed to:
    Prof. Ibrahim Eldaghayes
    Editor-in-Chief
    National Journal of Physiology, Pharmacy and Pharmacology
    Email: ibrahim.eldaghayes@vetmed.edu.ly
    POLICIES & JOURNAL LINKS
    Author Login
    Reviewer Login
    About Publisher
    Advertising Policy
    Author's Rights and Obligations
    Conflict of Interest Policy
    Copyright Information
    Digital Archiving & Preservation Policies
    Editorial Policies
    Peer Review Policy
    Editorial & Peer Review Process
    License Information
    Open Access Policy
    Plagiarism Policy
    Privacy Policy
    Protection of Research Participants (Statement On Human And Animal Rights)
    Publication Ethics and Publication Malpractice Statement
    Corrections, Retractions & Expressions of Concern
    Self-Archiving Policies
    Statement of Informed Consent
    Terms of Use